Features Screener Stocks Charts
Sign In Sign Up

Gufic Biosciences Income Statement

NSE:GUFICBIO | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year GUFICBIO income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 8.09B 8.20B
Cost of Revenue -3.90B -3.75B
Gross Profit 4.19B 4.45B
Sales, General & Admin -2.71B -3.09B
Operating Income 1.31B 1.15B
Profit Before Tax 1.16B 941.44M
Net Income 861.36M 696.49M
Diluted Shares 98.52M 100.28M
Diluted EPS 8.74 6.95

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025